Similar articles for PMID: 21898754

Year	Number of Results
1904	1
1946	1
1955	1
1956	1
1957	1
1983	1
1984	1
1988	1
1989	1
1991	1
1992	2
1993	1
1995	1
1996	1
1997	1
1998	2
1999	1
2000	3
2002	2
2003	1
2004	7
2005	2
2006	9
2007	7
2008	11
2009	10
2010	9
2011	6
2012	15
2013	13
2014	15
2015	14
2016	11
2017	9
2018	8
2019	8
2020	9
2021	7
2022	3
2023	3
2024	0

1

Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.

Mu PW, Chen YM, Lu HY, Wen XQ, Zhang YH, Xie RY, Shu J, Wang MM, Zeng LY. Mu PW, et al. Diabetes Metab Res Rev. 2012 Mar;28(3):236-40. doi: 10.1002/dmrr.1292. Diabetes Metab Res Rev. 2012. PMID: 21898754 Clinical Trial.

2

Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.

Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Ragonesi PD, Querci F, Franzetti IG, Gadaleta G, Ciccarelli L, Piccinni MN, D'Angelo A, Cicero AF. Derosa G, et al. Metabolism. 2010 Jun;59(6):887-95. doi: 10.1016/j.metabol.2009.10.007. Epub 2009 Dec 16. Metabolism. 2010. PMID: 20015525 Clinical Trial.

3

Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.

Derosa G, Franzetti IG, Querci F, Carbone A, Ciccarelli L, Piccinni MN, Fogari E, Maffioli P. Derosa G, et al. Diabet Med. 2012 Dec;29(12):1515-23. doi: 10.1111/j.1464-5491.2012.03699.x. Diabet Med. 2012. PMID: 22540883 Clinical Trial.

4

Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs.

Lankisch MR, Ferlinz KC, Leahy JL, Scherbaum WA; Orals Plus Apidra and LANTUS (OPAL) study group. Lankisch MR, et al. Diabetes Obes Metab. 2008 Dec;10(12):1178-85. doi: 10.1111/j.1463-1326.2008.00967.x. Diabetes Obes Metab. 2008. PMID: 19040645 Clinical Trial.

5

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.

Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P; Sitagliptin Study 035 Group. Hermansen K, et al. Diabetes Obes Metab. 2007 Sep;9(5):733-45. doi: 10.1111/j.1463-1326.2007.00744.x. Epub 2007 Jun 26. Diabetes Obes Metab. 2007. PMID: 17593236 Clinical Trial.

6

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H. Weng J, et al. Lancet. 2008 May 24;371(9626):1753-60. doi: 10.1016/S0140-6736(08)60762-X. Lancet. 2008. PMID: 18502299 Clinical Trial.

7

Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.

Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P; IMPROVE Study Group Expert Panel. Wenying Y, et al. Curr Med Res Opin. 2009 Nov;25(11):2643-54. doi: 10.1185/03007990903276745. Curr Med Res Opin. 2009. PMID: 19751116

8

Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim study.

Pfützner A, Derwahl M, Jacob S, Hohberg C, Blümner E, Lehmann U, Fuchs W, Forst T. Pfützner A, et al. Diabetes Technol Ther. 2010 Aug;12(8):599-604. doi: 10.1089/dia.2010.0019. Diabetes Technol Ther. 2010. PMID: 20615100 Clinical Trial.

9

Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.

Brazg R, Xu L, Dalla Man C, Cobelli C, Thomas K, Stein PP. Brazg R, et al. Diabetes Obes Metab. 2007 Mar;9(2):186-93. doi: 10.1111/j.1463-1326.2006.00691.x. Diabetes Obes Metab. 2007. PMID: 17300594 Clinical Trial.

10

The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.

Gao H, Xiao W, Wang C, Zhang J, Yang Y, Yang J, Yang W, Hong T. Gao H, et al. Int J Clin Pract. 2008 May;62(5):695-700. doi: 10.1111/j.1742-1241.2008.01733.x. Int J Clin Pract. 2008. PMID: 18412932 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

187 results

Results by year